NEW IMMUNIZATION SCHEDULE EFFECTIVENESS AGAINST HEPATITIS B IN LIVER TRANSPLANTATION PATIENTS.

Autor:	Rodrigues IC; Faculdade de Medicina de São José do Rio Preto - FAMERP, São José do Rio Preto, SP, Brasil., Silva RCMAD; Fundação Faculdade Regional de Medicina de São José do Rio Preto / Hospital de Base - FUNFARME/FAMERP/HB, São José do Rio Preto, SP, Brasil., Felício HCC; Fundação Faculdade Regional de Medicina de São José do Rio Preto / Hospital de Base - FUNFARME/FAMERP/HB, São José do Rio Preto, SP, Brasil., Silva RFD; Fundação Faculdade Regional de Medicina de São José do Rio Preto / Hospital de Base - FUNFARME/FAMERP/HB, São José do Rio Preto, SP, Brasil.
Jazyk:	angličtina
Zdroj:	Arquivos de gastroenterologia [Arq Gastroenterol] 2019 Oct-Dec; Vol. 56 (4), pp. 440-446.
DOI:	10.1590/S0004-2803.201900000-77
Abstrakt:	Background: Although liver transplantation is considered to be a high-risk procedure, it is well-established as a treatment option for the cure and quality of life enhancement for individuals who suffer from diseases. Preventing an infection by hepatitis B virus through immunization schedules has been the most effective way to reduce complications, since it decreases the number of people who suffer from chronic hepatitis caused by the hepatitis B virus and eradicates its transmission. Objective: 1. Analyzing evidence in the literature on various schedules employed for immunization against hepatitis B in patients who have received a liver transplantation. 2. Suggesting potential immunization schedules against hepatitis B in patients who suffer from liver cirrhosis, without previous verifying documentation, using the Child-Turcotte Pugh score, according to evidences found in the literature. Methods: Systematic review of the literature, conducted on the data bases MedLine, PubMed, and Lilacs, between September, 2017 and January, 2018, by using the following keywords: "Liver Transplantation, "Immunization Schedule", "Hepatitis B Vaccines". In order to analyze the articles, a summary figure was especially designed and both the results and discussion were presented in a descriptive way. Results: We included 24 studies; among them, eight had accelerated immunization schedules, 13 followed the conventional schedules, and three had super accelerated schedules. Regarding immunization, 21 studies were conducted with patients in the pre-transplant period, one with a transplanted patient, one with a pre-transplant group, and one with a post-transplant group. Found articles suggest that, disregarding the chosen immunization schedule, seroconversion rates tended to be lower as the liver disease advanced, compared to the healthy population. Conclusion: The studies did not find seroconversion superiority between the different immunization schedules (conventional and unconventional). However, since candidates to liver transplantation are usually very vulnerable, results show that super accelerated immunization schedules are possibly recommended for such group of patients; serologic test results will be higher when the immunization schedule is completed in the pre-transplant period.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu